The DPDP Act lands on hospital marketing teams on 14 May 2027. This is the operating manual: a consent matrix by channel, retargeting rules, WhatsApp opt-ins and the exact consent fields your CRM needs.
The argument is never really about headcount. It is about which work is continuous and which is episodic, and who stays accountable for the outcome once the contracts are signed.
A large share of international cases is paid for by somebody else. How sponsored referrals are actually won, what the paperwork demands, and where hospitals lose the relationship.
In this corridor somebody other than the family often pays. How guarantees of cover, employer schemes, referring consultants and settlement paperwork shape the case.
Two markets that will never move a monthly dashboard, and are worth holding anyway. How to run a low-volume source market at low cost without breaking a promise.
A family abroad cannot check your estimate against anything. They raise money against it and arrive. Whether the final bill matches decides your name in that market.
Since 6 October 2026, NMC guidelines bar patient testimonials and success stories, even with consent, including stories from international patients. What hospitals can still publish for source markets, and how to retire what is already live.
Cases from the Horn of Africa move as a sequence, not a conversation. Sponsors, split transfers, dated estimates and the arrival hours that decide the whole relationship.
The argument about intermediaries is really a channel design question. The answer differs by market, and getting it wrong costs you the ability to see your own demand.
Entry and documentation questions land in marketing channels, not at the international desk. The safe answer is never the rule itself, but the hospital’s own process and a route to the authority.
I use Google Analytics cookies to see which articles are useful. They stay off unless you accept. Privacy policy